These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29535138)

  • 1. Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy.
    Aguiar P; Azevedo O; Pinto R; Marino J; Cardoso C; Sousa N; Cunha D; Hughes D; Ducla Soares JL
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum versus Imaging Biomarkers in Friedreich Ataxia to Indicate Left Ventricular Remodeling and Outcomes.
    Mehta N; Chacko P; Jin J; Tran T; Prior TW; He X; Agarwal G; Raman SV
    Tex Heart Inst J; 2016 Aug; 43(4):305-10. PubMed ID: 27547137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.
    Ho CY; López B; Coelho-Filho OR; Lakdawala NK; Cirino AL; Jarolim P; Kwong R; González A; Colan SD; Seidman JG; Díez J; Seidman CE
    N Engl J Med; 2010 Aug; 363(6):552-63. PubMed ID: 20818890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed Stages of Myocardial Phenotype Development in Fabry Disease.
    Nordin S; Kozor R; Medina-Menacho K; Abdel-Gadir A; Baig S; Sado DM; Lobascio I; Murphy E; Lachmann RH; Mehta A; Edwards NC; Ramaswami U; Steeds RP; Hughes D; Moon JC
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1673-1683. PubMed ID: 29778854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of myocardial fibrosis by late gadolinium enhancement imaging and biomarkers of collagen metabolism in chronic rheumatic mitral regurgitation.
    Meel R; Nethononda R; Libhaber E; Dix-Peek T; Peters F; Essop M
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):150-154. PubMed ID: 29443354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Left Ventricular Reverse Remodeling and Outcomes by Circulating Collagen-Derived Peptides.
    Ravassa S; Lupón J; López B; Codina P; Domingo M; Revuelta-López E; Moreno MU; San José G; Santiago-Vacas E; Cediel G; Roncal C; Díez J; Bayés-Genís A; González A
    JACC Heart Fail; 2023 Jan; 11(1):58-72. PubMed ID: 36599551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA study.
    Weidemann F; Beer M; Kralewski M; Siwy J; Kampmann C
    Mol Genet Metab; 2019 Feb; 126(2):169-182. PubMed ID: 30594474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial collagen turnover in hypertrophic cardiomyopathy.
    Lombardi R; Betocchi S; Losi MA; Tocchetti CG; Aversa M; Miranda M; D'Alessandro G; Cacace A; Ciampi Q; Chiariello M
    Circulation; 2003 Sep; 108(12):1455-60. PubMed ID: 12952838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.
    Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; O'Moore-Sullivan T; Marwick TH
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1239-49. PubMed ID: 22172779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Yang C; Qiao S; Song Y; Liu Y; Tang Y; Deng L; Yuan J; Hu F; Yang W
    Cardiovasc Pathol; 2019; 43():107150. PubMed ID: 31639652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
    Niemann M; Herrmann S; Hu K; Breunig F; Strotmann J; Beer M; Machann W; Voelker W; Ertl G; Wanner C; Weidemann F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):592-601. PubMed ID: 21679893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.
    Mathur S; Dreisbach JG; Karur GR; Iwanochko RM; Morel CF; Wasim S; Nguyen ET; Wintersperger BJ; Hanneman K
    J Cardiovasc Magn Reson; 2019 Aug; 21(1):45. PubMed ID: 31366357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy.
    Nordin S; Kozor R; Vijapurapu R; Augusto JB; Knott KD; Captur G; Treibel TA; Ramaswami U; Tchan M; Geberhiwot T; Steeds RP; Hughes DA; Moon JC
    Circ Cardiovasc Imaging; 2019 Dec; 12(12):e009430. PubMed ID: 31826677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy - A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy.
    Raafs AG; Verdonschot JAJ; Henkens MTHM; Adriaans BP; Wang P; Derks K; Abdul Hamid MA; Knackstedt C; van Empel VPM; Díez J; Brunner-La Rocca HP; Brunner HG; González A; Bekkers SCAM; Heymans SRB; Hazebroek MR
    Eur J Heart Fail; 2021 Jun; 23(6):933-944. PubMed ID: 33928704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of primary coronary intervention on myocardial collagen metabolism and left ventricle remodeling predicted by collagen metabolism markers.
    Jirmár R; Pelouch V; Widimský P; Capek J; Andel M; Průsa R; Pechová M
    Int Heart J; 2005 Nov; 46(6):949-59. PubMed ID: 16394591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of carboxyterminal propeptide of type I procollagen and left ventricular remodeling after myocardial infarction.
    Takino T; Nakamura M; Hiramori K
    Cardiology; 1999; 91(2):81-6. PubMed ID: 10449877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.
    Flevari P; Theodorakis G; Leftheriotis D; Kroupis C; Kolokathis F; Dima K; Anastasiou-Nana M; Kremastinos D
    Am Heart J; 2012 Oct; 164(4):530-7. PubMed ID: 23067911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of collagen metabolism predict the left ventricular remodeling after myocardial infarction.
    Radovan J; Vaclav P; Petr W; Jan C; Michal A; Richard P; Martina P
    Mol Cell Biochem; 2006 Dec; 293(1-2):71-8. PubMed ID: 16933032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the PPARGC1A Gly482Ser polymorphism on left ventricular structural and functional abnormalities in patients with hypertension.
    Rojek A; Cielecka-Prynda M; Przewlocka-Kosmala M; Laczmanski L; Mysiak A; Kosmala W
    J Hum Hypertens; 2014 Sep; 28(9):557-63. PubMed ID: 24718382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis.
    Lebedev DA; Lyasnikova EA; Vasilyeva EY; Babenko AY; Shlyakhto EV
    J Diabetes Res; 2020; 2020():6976153. PubMed ID: 33224989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.